ANNOUNCEMENT! My FB LIVE ON BIRTH CONTROL OPTIONS AND NIGHTMARES! In a little less than 2 1/2 hours at 7PM MST. Will also take follow up questions on fibromyalgia or IC. HERE’S A LIST TO PONDER:
KNOWN PROBLEMS WITH BIRTH CONTROL OPTIONS
Aloha cherished Friends & Guests, Breast cancer can turn life upside down and make life a rollercoaster physically, mentally, and emotionally. This topic is close to my heart after losing loved ones to cancer and fighting breast cancer myself. I hope this blog helps promote proactive prevention as many people do not think about cancer until it is too late. In recent years, vast improvements in treatment save many more lives through new information and evolving ideas. However, too many are still affected by this disease which is why treatment and prevention must continue to improve. I am fortun
CCL11 encodes eotaxin-1, a chemokine best known for attracting eosinophils. Its receptor relationships connect it to allergic inflammation as well as broader research into immune signaling.
CCL3 encodes MIP-1 alpha, a chemokine involved in attracting and activating immune cells. It is related to CCL4, or MIP-1 beta, but the two genes and proteins are distinct.
CCL4 encodes MIP-1 beta, a chemokine involved in attracting immune cells. It participates in a recruitment network that includes CCL2, CXCL8 and related chemokines.
TGFB1 encodes transforming growth factor beta 1, which has roles in immune regulation, tissue repair and extracellular-matrix production. Its effects can include both regulation of inflammation and promotion of fibrosis.
Search looks for your words in titles, descriptions, available articles, learning guides, and video captions when available. The closest matches appear first. Duplicate posts are grouped, with links to other places you can read or watch them. Books, chapters, and reports have topic guides here; the original files and full book text are not available in this encyclopedia. Subscriber posts include a title and public summary; open Substack to read the full post.